A Manuscript on the Preclinical Development of EXT608 Has Been Published
A manuscript titled, “Preclinical development of EXT608, an investigational parathyroid hormone derivative with extended half-life for the treatment of hypoparathyroidism” by DH Hall, CH Kostyla, LM Hales and TM Soliman has been published in the Journal of Bone Mineral Research Plus.